Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family member C19 pseudogene 5 (DNAJC19P5) is a pseudogene locus in the human genome and is designated as such because it is a non-functional copy related to the functional DNAJC19 gene, which encodes a mitochondrial cochaperone involved in protein folding. Unlike the functional gene, DNAJC19P5 does not encode an active protein and lacks evidence for transcription, protein translation, or biological function. Pseudogenes like DNAJC19P5 are typically formed by duplication or retrotransposition followed by sequence mutation that disables normal gene activity. While some pseudogenes can have regulatory roles in disease processes, there is no evidence of such activity for DNAJC19P5. It is cataloged in genetic databases for reference but is not considered a molecular or therapeutic target[5][2][3].
None known. No mechanism of action described for drugs or interventions acting on DNAJC19P5
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family member C19 pseudogene 5 (DNAJC19P5).